Kozak & Associates’s MetLife MET Stock Holding History

Kozak & Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.06K	Hold	11	–	–	﹤0.01%	358
2026 Q2	$940	Sell	11 -2	-15%	-$161	﹤0.01%	386
2026 Q1	$957	Hold	13	–	–	﹤0.01%	397
2025 Q4	$1K	Hold	13	–	–	﹤0.01%	390
2025 Q3	$944	Hold	13	–	–	﹤0.01%	408
2025 Q2	$1.02K	Sell	13 -85	-87%	-$6.56K	﹤0.01%	370
2025 Q1	$7.17K	Sell	98 -215	-69%	-$17.9K	﹤0.01%	247
2024 Q4	$25.7K	Sell	313 -74	-19%	-$6.16K	0.01%	167
2024 Q3	$33K	Buy	387 +3	+0.8%	+$224	0.01%	155
2024 Q2	$26.9K	Buy	384 +3	+0.8%	+$214	0.01%	157
2024 Q1	$28K	Buy	381 +13	+4%	+$906	0.01%	160
2023 Q4	$25.1K	Sell	368 -535	-59%	-$33.5K	0.01%	174
2023 Q3	$55.4K	Sell	903 -210	-19%	-$13.1K	0.02%	130
2023 Q2	$63.8K	Hold	1,113	–	–	0.03%	125
2023 Q1	$64.5K	Sell	1,113 -137	-11%	-$9.25K	0.03%	130
2022 Q4	$90K	Hold	1,250	–	–	0.04%	117
2022 Q3	$79K	Hold	1,250	–	–	0.05%	117
2022 Q2	$79K	Buy	1,250 +8	+0.6%	+$530	0.05%	122
2022 Q1	$80K	Hold	1,242	–	–	0.05%	127
2021 Q4	$80K	Buy	1,242 +145	+13%	+$9.1K	0.05%	127
2021 Q3	$70K	Buy	+1,097	New	+$66K	0.04%	132

Other funds holding MET

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Kozak & Associates's MET Position: Q3 2026 in Review

Kozak & Associates held its MetLife (MET) position steady in Q3 2026 at 11 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #358.

Kozak & Associates first reported a position in MET in Q3 2021 and has held it in 21 quarters since. The position peaked at $90K in Q4 2022. 1,309 funds tracked by Wall St. Rank hold MET as of Q3 2026.

Kozak & Associates held 11 shares of MetLife worth $1.06K as of Q3 2026.
Kozak & Associates left its MetLife share count unchanged in Q3 2026.
MetLife made up ﹤0.01% of Kozak & Associates's portfolio in Q3 2026, its #358 holding.
Kozak & Associates first reported a position in MetLife in Q3 2021 and has held it in 21 quarters since.
Kozak & Associates's MetLife position peaked at $90K in Q4 2022.
1,309 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Kozak & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.